Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
180.00    1.00 (0.56%)
Bid:
180.00
Ask:
184.00
Spread: 4.00 (2.222%)
Market Cap: £34.98m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Director/PDMR Shareholding

5 Dec 2017 18:19

RNS Number : 4855Y
Palace Capital PLC
05 December 2017
 

Palace Capital plc

("Palace Capital" or the "Company")

 

Director/PDMR shareholding

 

The Board of Palace Capital was notified today that Neil Sinclair, Chief Executive of the Company, has sold 20,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 337 pence per Ordinary Share. Mr Sinclair has sold these shares in order to fund a personal tax bill relating to 39,811 shares having been awarded under the Company's 2014 Long Term Incentive Plan. As a result of this transaction Mr Sinclair's holding in the Company is 212,761 Ordinary Shares, which represents approximately 0.46 per cent. of the voting rights over the Company's share capital.

 

In addition, David Kaye, Company Secretary and a PDMR, has sold 6,635 Ordinary Shares at a price of 335 pence per Ordinary Share. These shares were awarded to Mr Kaye under the Company's 2014 Long Term Incentive Plan. Following this sale Mr Kaye no longer has a holding in the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Neil Sinclair

2

Reason for the notification

a)

Position/status

Chief Executive

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Palace Capital plc

b)

LEI

2138009JDFQOXJFCJQ05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Palace Capital plc

 

Identification code (ISIN) for Palace Capital plc ordinary shares: GB00BF5SGF06

b)

Nature of the transaction

Sale of shares

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

337p

20,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

5th December 2017

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

 1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Kaye

2

Reason for the notification

a)

Position/status

Company Secretary (PDMR)

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Palace Capital plc

b)

LEI

2138009JDFQOXJFCJQ05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Palace Capital plc

 

Identification code (ISIN) for Palace Capital plc ordinary shares: GB00BF5SGF06

b)

Nature of the transaction

Sale of shares

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

337p

6,635

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

5th December 2017

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

Date: 5th December 2017

 

For further information, contact:

 

Palace Capital plc

Neil Sinclair, Chief Executive

Stephen Silvester, Finance Director

Tel. +44 (0)20 3301 8331

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Nick Naylor / James Reeve / Asha Chotai

Tel. +44 (0)20 3328 5656

 

Arden Partners plc (Joint Broker)

Chris Hardie / Ciaran Walsh

Tel. +44 (0)207 614 5917

 

Capital Access Group (Financial PR)

Scott Fulton

Tel. +44 (0)20 3763 3400

 

About Palace Capital plc (www.palacecapitalplc.com):

 

Palace Capital is a UK property investment company admitted to trading on AIM, a market operated by the London Stock Exchange (LSE: PCA). The Company is not sector specific and looks for opportunities where it can enhance the long-term income and capital value through asset management and strategic capital development in locations outside London. In its last reported financial year, Palace Capital produced a 20.0% increase in adjusted profit before tax, a 7.0% uplift in EPRA NAV per share and a 16.0% increase in dividends.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFLTFALEIID
Date   Source Headline
5th Mar 20212:22 pmRNSHolding(s) in Company
17th Feb 20212:43 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSUpdate on rent collection
21st Dec 202012:05 pmEQSHardman & Co Research: Q&A with Mike Foster on Palace Capital (PCA): Interim results on track - upside clear in FY'22
26th Nov 20208:00 amEQSPalace Capital (PCA): COVID-19 impacts actively managed
24th Nov 20205:20 pmEQSHardman & Co Research: Palace Capital (PCA): Interim results on track - upside clear in FY'22
17th Nov 20207:00 amRNSHalf-year Report
13th Nov 20207:00 amRNSInvestor Presentation
26th Oct 20203:00 pmRNSDirector/PDMR Shareholding
16th Oct 20202:09 pmRNSDirector Dealing
13th Oct 20207:00 amRNSUpdate on trading and rent collection
7th Oct 20203:40 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSHolding(s) in Company
2nd Oct 20207:00 amRNSHolding(s) in Company
2nd Oct 20207:00 amRNSReduction of Share Premium Account
15th Sep 20207:00 amRNSDividend Declaration
4th Sep 20202:00 pmEQSHardman & Co Research: Hardman Talks: Palace Capital interview with Mike Foster
7th Aug 20201:40 pmRNSResult of AGM
15th Jul 20201:55 pmRNSNotice of AGM
15th Jul 20207:00 amRNSGrant of awards under Deferred Bonus Plan
14th Jul 20203:05 pmEQSHardman & Co Research: Palace Capital (PCA): Encouraging full-year results
13th Jul 20207:00 amRNSDirector/PDMR Shareholding
9th Jul 20203:28 pmRNSDirector/PDMR Dealing
7th Jul 20202:52 pmRNSFinal Results for the year ended 31 March 2020
7th Jul 20207:00 amRNSFinal Results for the year ended 31 March 2020
3rd Jul 20205:03 pmRNSHolding(s) in Company
3rd Jul 20202:40 pmRNSNotice of Results & Investor Presentation
17th Jun 20205:45 pmEQSCORRECTION: Hardman & Co Research: Palace Capital presenting at virtual Investor Forum on 9th July 2020
17th Jun 20209:27 amEQSHardman & Co Research: Palace Capital presenting at virtual Investor Forum on 9th July 2020
27th Apr 20202:33 pmRNSDirector Dealing
27th Apr 202012:08 pmRNSSecond Price Monitoring Extn
27th Apr 202012:02 pmRNSPrice Monitoring Extension
17th Apr 20207:00 amRNSInvestor presentation
7th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20203:20 pmEQSHardman & Co Research: Palace Capital (PCA): Trading update and COVID-related dividend cut
2nd Apr 20207:00 amRNSCOVID-19 and dividend update
27th Mar 202010:09 amRNSDirector Dealing
10th Mar 20207:00 amRNSDividend Declaration
10th Feb 20204:40 pmRNSSecond Price Monitoring Extn
10th Feb 20204:35 pmRNSPrice Monitoring Extension
10th Feb 20207:00 amRNSRecord office rent in Hudson Quarter, York
3rd Feb 20207:00 amRNSAppointment of Non-Executive Director
27th Jan 202012:07 pmRNSSecond Price Monitoring Extn
27th Jan 202012:02 pmRNSPrice Monitoring Extension
8th Jan 202011:48 amRNSDirector dealing
12th Dec 201912:07 pmRNSSecond Price Monitoring Extn
12th Dec 201912:02 pmRNSPrice Monitoring Extension
9th Dec 20197:00 amRNSPALACE CAPITAL DISPOSES OF BIRMINGHAM ASSET
27th Nov 20193:35 pmEQSHardman & Co Research: Palace Capital (PCA): 1H'20 results announced
19th Nov 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.